Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: A subgroup analysis by baseline variables in the PIONEER 9 and PIONEER 10 trials.
Daisuke YabeSrikanth DeenadayalanHiroshi HorioHideaki KanetoThomas Bo JensenYasuo TerauchiYuichiro YamadaNobuya InagakiPublished in: Journal of diabetes investigation (2022)
Oral semaglutide is effective across a range of baseline subgroups of Japanese patients with type 2 diabetes, with no unexpected safety findings.
Keyphrases